Scleroderma

Scleroderma — The Disease That Turns Your Own Body Into Stone

By Cami Grasher | My Root Cause Coach

June is Scleroderma Awareness Month, and this article is for the people who have it and feel invisible, for the people who love someone who has it and do not fully understand what their body is going through, and for everyone else, because scleroderma is one of the most misunderstood, most underdiagnosed, and most isolating autoimmune conditions in existence, and the people living with it deserve more than the minimal public attention this disease currently receives.

Scleroderma. The name comes from the Greek words for hard skin. And while the name captures one visible aspect of the disease, it fails almost completely to convey what systemic sclerosis, the full name for its most serious form, actually does to a human body.

This is not a skin condition. It is a systemic autoimmune disease that can affect the skin, the joints, the blood vessels, the esophagus, the lungs, the heart, and the kidneys simultaneously, in a progression that is different for every person who has it, and for which there is currently no cure.

What Is Actually Happening in the Body

Scleroderma is an autoimmune disease, which means the immune system, the system designed to protect the body from outside threats, turns against the body's own tissue. In scleroderma, this immune dysregulation triggers two interconnected processes that drive almost all of the disease's damage: inflammation and fibrosis.

Fibrosis is the excessive and abnormal production of collagen, the structural protein that gives connective tissue its strength and shape. In a healthy body, collagen production is tightly regulated, deployed in response to injury to repair tissue and then switched off when the repair is complete. In scleroderma, that regulatory system breaks down. The immune system sends signals that trick fibroblasts, the cells responsible for producing collagen, into continuous overproduction. Collagen accumulates in the skin and in internal organs, making them progressively thicker, stiffer, and less functional.

This is what turns skin hard and tight, what makes it difficult to open the mouth fully or close the fingers, what narrows the esophagus until swallowing becomes difficult, what stiffens lung tissue until breathing becomes labored, and what thickens the walls of blood vessels until circulation is severely compromised. It is the same biological process, inappropriate and uncontrolled collagen deposition, expressing itself across every system the blood vessels supply.

Vascular damage is the other central feature of scleroderma, and in many ways it is the most dangerous one. The small blood vessels throughout the body are damaged early in the disease process, leading to poor circulation to the fingers, toes, and skin, and in more severe cases to the internal organs. Raynaud's phenomenon, in which the fingers and toes change color dramatically in response to cold or stress, turning white, then blue, then red as circulation is cut off and then restored, is one of the earliest and most consistent features of systemic sclerosis and often precedes the skin changes by months or years. For many people it is the first warning the body sends, and it is frequently dismissed as simply poor circulation or cold sensitivity rather than recognized as the vascular autoimmune signal it often is.

The Two Forms and What They Mean

Systemic sclerosis comes in two primary forms that differ significantly in their scope and progression. Limited cutaneous systemic sclerosis, formerly called CREST syndrome, primarily affects the skin of the hands, face, and lower arms and legs, and tends to progress more slowly. Raynaud's phenomenon is typically prominent. Internal organ involvement, while possible, tends to develop later and in a smaller proportion of patients, although pulmonary arterial hypertension is a significant risk in this group.

Diffuse cutaneous systemic sclerosis involves widespread skin thickening that can extend to the trunk, and is more likely to involve internal organs earlier and more severely. Lung involvement in the form of interstitial lung disease is present in 50 to 80% of patients with systemic sclerosis and accounts for approximately 40% of all deaths from the disease. Pulmonary arterial hypertension, kidney involvement, and cardiac complications are also possible in diffuse disease, making close medical monitoring essential from the time of diagnosis.

Scleroderma predominantly affects women, particularly between the ages of 30 and 50, though it can occur at any age and in men as well. It is classified as a rare disease, meaning it affects fewer than 200,000 people in the United States, but rare does not mean minor. For those living with systemic sclerosis, the disease touches every aspect of daily life.

The Invisible Symptoms Nobody Talks About

Because scleroderma is primarily understood by the public as a skin disease, it's invisible and internal symptoms frequently go unacknowledged, which creates a particular kind of isolation for people living with it. The physical symptoms that others cannot see are often the ones that most profoundly affect quality of life.

Fatigue in scleroderma is not ordinary tiredness. It is the deep, systemic exhaustion of a body in which the immune system is chronically activated, multiple organ systems are under stress, and sleep is often disrupted by pain, reflux, and breathing difficulties. Research has consistently identified fatigue as one of the most debilitating symptoms reported by scleroderma patients, and it is one that is frequently minimized in clinical settings because it does not show up on a scan or a lab test.

Gastrointestinal involvement affects up to 90% of people with systemic sclerosis, making it one of the most common internal manifestations of the disease. Fibrosis of the smooth muscle of the esophagus and intestines can cause severe acid reflux, difficulty swallowing, bloating, constipation, diarrhea, malabsorption, and in severe cases a form of intestinal dysfunction that significantly compromises nutrition. Many patients describe spending more mental energy managing their digestive symptoms than any other aspect of the disease.

Pain, joint stiffness, and limited range of motion affect the hands, fingers, and other joints in ways that make daily tasks, from buttoning a shirt to opening a jar to typing, genuinely difficult. The characteristic tightening of skin over the hands can fuse the fingers into a partially flexed position over time. Facial skin tightening can reduce the ability to open the mouth fully, which affects eating, dental care, and facial expression in ways that are both physically challenging and psychologically isolating.

The psychological impact of scleroderma is significant and underaddressed. The combination of a changed physical appearance, chronic pain and fatigue, unpredictable disease progression, significant limitations in daily function, and inadequate public awareness of the condition creates conditions for depression, anxiety, and social withdrawal that compound the physical disease burden in ways that the medical system often does not have adequate time or resources to address.

What the Root Cause Lens Adds to This Conversation

Systemic sclerosis does not have an identified single cause. Research points to a convergence of genetic predisposition, environmental triggers including occupational silica dust exposure, certain solvents, and possibly viral triggers, and immune dysregulation as the conditions under which the disease develops. It is not something a person did wrong. It is not preventable in the conventional sense for those who are genetically susceptible.

What the root cause perspective contributes to living with scleroderma is not a cure. It is a framework for supporting the body's function as comprehensively as possible within the reality of the disease.

Reducing the overall inflammatory burden matters in autoimmune conditions in the same way it matters everywhere else in the body. An anti-inflammatory dietary pattern that eliminates ultraprocessed foods, refined carbohydrates, and inflammatory seed oils while emphasizing colorful vegetables, quality proteins, omega-3 fatty acids, and fiber-rich whole foods addresses the background inflammatory environment even when it cannot reverse the underlying autoimmune process. For gastrointestinal involvement specifically, working with a practitioner to identify food sensitivities, support gut barrier integrity, and optimize nutrient absorption becomes critically important because malabsorption in scleroderma can create downstream deficiencies that amplify fatigue, immune dysfunction, and tissue health.

Vitamin D is particularly relevant in the context of autoimmune disease broadly and scleroderma specifically, as immune regulation is one of its primary functions and deficiency is common in autoimmune populations. Magnesium, B vitamins, and antioxidant nutrients are all frequently depleted in chronic inflammatory conditions and support the cellular energy and tissue maintenance functions that matter for quality of life in a long-term disease. Raynaud's phenomenon specifically responds in some patients to dietary and lifestyle interventions including avoiding cold exposure, quitting smoking, managing stress, and ensuring adequate essential fatty acid intake, which supports vascular tone and circulation.

Stress management is not optional in autoimmune disease. The immune system and the nervous system are in continuous communication, and chronic psychological stress drives the kind of sustained immune activation that worsens autoimmune conditions across the board. This is not about telling someone with scleroderma to simply relax. It is about recognizing that a nervous system in chronic fight-or-flight mode is immunologically more active in ways that are not helpful, and that practices including breathwork, gentle movement, adequate sleep, and genuine social connection are not luxuries but therapeutic inputs.

What You Should Do If You or Someone You Love Has Scleroderma

Care for systemic sclerosis requires a rheumatologist with specific experience in the disease and, depending on which organ systems are involved, a pulmonologist, cardiologist, gastroenterologist, and physical or occupational therapist as well. Because the disease is relatively rare, finding a center with a dedicated scleroderma program offers the most comprehensive and current treatment expertise.

Current medical treatments focus on managing specific complications including immunosuppressive therapy for lung disease, medications for pulmonary arterial hypertension, proton pump inhibitors and motility agents for gastrointestinal involvement, and calcium channel blockers for Raynaud's phenomenon. Newer biological therapies targeting the fibrotic and immune pathways driving the disease are an active area of research, and clinical trial participation through a specialized center may offer access to emerging options.

The Scleroderma Foundation at scleroderma.org provides patient support, provider directories, and educational resources.

Nobody with this disease should have to navigate it alone, and connecting with others who understand the experience of living in a body that is fighting itself in ways that most people cannot see is one of the most powerful supports available.

Awareness is the beginning of everything. It drives research funding, clinical training, and the recognition in doctors' offices that catches the disease earlier, when intervention matters most. This month and every month after it, scleroderma deserves more of both.

If you need support, please Book a Discovery Call with Cami Grasher. Call/text (214) 558-0996 or click the button below to book online.

Book with Cami